FIELD: medicine; pharmacology.
SUBSTANCE: disclosed is application of the known medicinal agent, sigma-1 receptor agonist of 5-ethoxy-2-[2-(morpholino)-ethylthio]-benzimidazole dihydrochloride (afobazole) as an agent for preventing sudden cardiac death in patients suffering alcoholic cardiomyopathy.
EFFECT: technical result is agonist sigma-1 receptor afobazole in conditions of formed alcoholic cardiomyopathy restores electrical stability of myocardium, increases its compensatory capabilities and contractility - the main independent predictors of sudden cardiac death in the declared conditions, including the abstinence syndrome caused by the termination of prolonged alcohol abuse.
1 cl, 3 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ALCOHOLIC CARDIOMYOPATHY SIMULATION | 2013 |
|
RU2646454C2 |
| DRUG PREPARATION WITH CARDIOPROTECTIVE ACTIVITY | 2010 |
|
RU2476224C2 |
| DRUG PREPARATION WITH ANTIARRHYTHMIC AND ANTIFIBRILLATORY ACTION | 2010 |
|
RU2477144C2 |
| CARDIOTROPIC AGENT WITH ANXIOLYTIC AND ANALGESIC PROPERTIES | 2020 |
|
RU2773018C2 |
| AGENT FOR MANAGING ALCOHOL ABSTINENCE SYNDROME | 2012 |
|
RU2521226C2 |
| MEANS FOR REDUCING ALCOHOL MOTIVATION IN ALCOHOL DEPENDENCE | 2014 |
|
RU2582966C2 |
| AGENT FOR INCREASING RESISTANCE OF HEART TO ARRYTHMOGENIC ACTION OF ISCHAEMIA AND REPERFUSION | 2014 |
|
RU2587783C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING GASTRIC TACHYCARDIA IN PATIENTS WITH CORONARY HEART DISEASE | 2021 |
|
RU2752362C1 |
| METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF HYPERTROPHIC CARDIOMYOPATHY | 2013 |
|
RU2527768C1 |
| AGENT IMPROVING CARDIAC RESISTANCE TO ISCHEMIC AND FOLLOWING REPERFUSION INJURIES | 2012 |
|
RU2488404C1 |
